National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

interleukin-2 liposome
A formulation in which liposomes are loaded with the cytokine interleukin-2 (IL-2). By activating cytotoxic T-lymphocytes, such as lymphokine-activated killer cells, and increasing levels of the cytotoxic cytokines interferon-gamma (IFN-gamma) and transforming growth factor-beta (TGF-beta), IL-2 may exhibit antitumoral activity. Liposomal formulations of IL-2 may promote entry of the cytokine into target tumor cells and may be used as an immunoadjuvant in cancer vaccine therapy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Liposome encapsulated interleukin-2
Abbreviation:IL-2 LIPO



Previous:inotuzumab ozogamicin, integrin-targeted immunoconjugate IMGN388, interferon alfacon-1, interleukin-12 gene, interleukin-2 gene
Next:IntraDose, intranasal ketamine, Intron A, Intron A, inulin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov